Abstracts voorjaarsvergadering NVU, 16 en 17 mei 2019, Rotterdam
Samenvatting De FUTURE trial is een multicenter RCT naar MRI target biopten (TB’s) bij patiënten met negatieve systematische biopten (SB’s) en een verdenking op prostaatkanker. In deze analyse werden adverse events (AE) van drie technieken van TB vergeleken.
Gespeichert in:
Veröffentlicht in: | Tijdschrift voor urologie 2019-05, Vol.9 (Suppl 1), p.2-29 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | dut |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 29 |
---|---|
container_issue | Suppl 1 |
container_start_page | 2 |
container_title | Tijdschrift voor urologie |
container_volume | 9 |
creator | Mulders, Peter F. A. |
description | Samenvatting
De FUTURE trial is een multicenter RCT naar MRI target biopten (TB’s) bij patiënten met negatieve systematische biopten (SB’s) en een verdenking op prostaatkanker. In deze analyse werden adverse events (AE) van drie technieken van TB vergeleken. |
doi_str_mv | 10.1007/s13629-019-0255-6 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2786217684</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2786217684</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1566-72d1d4c78c786dd3cd653b136c84c1f6d6fb2aba46ae7e011a040d3d6dc2048a3</originalsourceid><addsrcrecordid>eNp1UMFKAzEQDaJgqf0AbwGvXc0k2cl6sxStQlEQ6zVkk2xpsd062Rb8e1O24MlhhpnDvPdmHmPXIG5BCHOXQKG8LwTkkmVZ4BkbSAlQaAPV-WlWQplLNkppLXKgkFDpAXuY1Kkj57vED21La-coHSItXYi02i756-dizAF53HIwfBNXXGaZMX9vuy5ScJsrdtG4rxRHpz5ki6fHj-lzMX-bvUwn88JDiVgYGSBob6qcGILyAUtV57t9pT00GLCppaudRhdNFABOaBFUwOCl0JVTQ3bT8-6o_d7H1Nl1u6dtlrQyU0owWOm8Bf2WpzYlio3d0Wrj6MeCsEevbO-VzU_Yo1cWM0b2mLQ7vhzpj_l_0C82i2jV</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2786217684</pqid></control><display><type>article</type><title>Abstracts voorjaarsvergadering NVU, 16 en 17 mei 2019, Rotterdam</title><source>Alma/SFX Local Collection</source><source>Springer Nature OA Free Journals</source><creator>Mulders, Peter F. A.</creator><creatorcontrib>Mulders, Peter F. A.</creatorcontrib><description>Samenvatting
De FUTURE trial is een multicenter RCT naar MRI target biopten (TB’s) bij patiënten met negatieve systematische biopten (SB’s) en een verdenking op prostaatkanker. In deze analyse werden adverse events (AE) van drie technieken van TB vergeleken.</description><identifier>ISSN: 2211-3037</identifier><identifier>EISSN: 2211-4718</identifier><identifier>DOI: 10.1007/s13629-019-0255-6</identifier><language>dut</language><publisher>Houten: Bohn Stafleu van Loghum</publisher><subject>Abstracts ; Medicine & Public Health ; Urology</subject><ispartof>Tijdschrift voor urologie, 2019-05, Vol.9 (Suppl 1), p.2-29</ispartof><rights>The Author(s) 2019</rights><rights>The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s13629-019-0255-6$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://doi.org/10.1007/s13629-019-0255-6$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,27901,27902,41096,42165,51551</link.rule.ids></links><search><creatorcontrib>Mulders, Peter F. A.</creatorcontrib><title>Abstracts voorjaarsvergadering NVU, 16 en 17 mei 2019, Rotterdam</title><title>Tijdschrift voor urologie</title><addtitle>Tijdschr Urol</addtitle><description>Samenvatting
De FUTURE trial is een multicenter RCT naar MRI target biopten (TB’s) bij patiënten met negatieve systematische biopten (SB’s) en een verdenking op prostaatkanker. In deze analyse werden adverse events (AE) van drie technieken van TB vergeleken.</description><subject>Abstracts</subject><subject>Medicine & Public Health</subject><subject>Urology</subject><issn>2211-3037</issn><issn>2211-4718</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>BENPR</sourceid><recordid>eNp1UMFKAzEQDaJgqf0AbwGvXc0k2cl6sxStQlEQ6zVkk2xpsd062Rb8e1O24MlhhpnDvPdmHmPXIG5BCHOXQKG8LwTkkmVZ4BkbSAlQaAPV-WlWQplLNkppLXKgkFDpAXuY1Kkj57vED21La-coHSItXYi02i756-dizAF53HIwfBNXXGaZMX9vuy5ScJsrdtG4rxRHpz5ki6fHj-lzMX-bvUwn88JDiVgYGSBob6qcGILyAUtV57t9pT00GLCppaudRhdNFABOaBFUwOCl0JVTQ3bT8-6o_d7H1Nl1u6dtlrQyU0owWOm8Bf2WpzYlio3d0Wrj6MeCsEevbO-VzU_Yo1cWM0b2mLQ7vhzpj_l_0C82i2jV</recordid><startdate>20190501</startdate><enddate>20190501</enddate><creator>Mulders, Peter F. A.</creator><general>Bohn Stafleu van Loghum</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20190501</creationdate><title>Abstracts voorjaarsvergadering NVU, 16 en 17 mei 2019, Rotterdam</title><author>Mulders, Peter F. A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1566-72d1d4c78c786dd3cd653b136c84c1f6d6fb2aba46ae7e011a040d3d6dc2048a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>dut</language><creationdate>2019</creationdate><topic>Abstracts</topic><topic>Medicine & Public Health</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mulders, Peter F. A.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Tijdschrift voor urologie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mulders, Peter F. A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Abstracts voorjaarsvergadering NVU, 16 en 17 mei 2019, Rotterdam</atitle><jtitle>Tijdschrift voor urologie</jtitle><stitle>Tijdschr Urol</stitle><date>2019-05-01</date><risdate>2019</risdate><volume>9</volume><issue>Suppl 1</issue><spage>2</spage><epage>29</epage><pages>2-29</pages><issn>2211-3037</issn><eissn>2211-4718</eissn><abstract>Samenvatting
De FUTURE trial is een multicenter RCT naar MRI target biopten (TB’s) bij patiënten met negatieve systematische biopten (SB’s) en een verdenking op prostaatkanker. In deze analyse werden adverse events (AE) van drie technieken van TB vergeleken.</abstract><cop>Houten</cop><pub>Bohn Stafleu van Loghum</pub><doi>10.1007/s13629-019-0255-6</doi><tpages>28</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2211-3037 |
ispartof | Tijdschrift voor urologie, 2019-05, Vol.9 (Suppl 1), p.2-29 |
issn | 2211-3037 2211-4718 |
language | dut |
recordid | cdi_proquest_journals_2786217684 |
source | Alma/SFX Local Collection; Springer Nature OA Free Journals |
subjects | Abstracts Medicine & Public Health Urology |
title | Abstracts voorjaarsvergadering NVU, 16 en 17 mei 2019, Rotterdam |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T00%3A58%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Abstracts%20voorjaarsvergadering%20NVU,%2016%20en%2017%20mei%202019,%20Rotterdam&rft.jtitle=Tijdschrift%20voor%20urologie&rft.au=Mulders,%20Peter%20F.%20A.&rft.date=2019-05-01&rft.volume=9&rft.issue=Suppl%201&rft.spage=2&rft.epage=29&rft.pages=2-29&rft.issn=2211-3037&rft.eissn=2211-4718&rft_id=info:doi/10.1007/s13629-019-0255-6&rft_dat=%3Cproquest_cross%3E2786217684%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2786217684&rft_id=info:pmid/&rfr_iscdi=true |